Patrick Sung Selected Research

Patrick Sung Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 05/2003
15	Genomic Instability 01/2022 - 11/2007
6	Bloom Syndrome 01/2022 - 10/2006
5	Fanconi Anemia (Fanconi's Anemia) 12/2020 - 03/2010
5	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2012
4	Chromosome Breakage 07/2017 - 10/2008
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 10/2008
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 03/2010
3	Bone Marrow Failure Disorders 12/2019 - 05/2006
3	Chromosomal Instability (Chromosome Stability) 09/2009 - 02/2006
2	Rothmund-Thomson Syndrome (Syndrome, Rothmund-Thomson) 09/2009 - 02/2006
1	Leiomyoma (Uterine Fibroids) 01/2022
1	Glioma (Gliomas) 12/2021
1	Glioblastoma (Glioblastoma Multiforme) 12/2021
1	Infections 10/2019
1	Genetic Translocation (Chromosomal Translocation) 01/2019
1	Xeroderma Pigmentosum (Kaposi's Disease) 02/2016
1	Skin Neoplasms (Skin Cancer) 02/2016
1	Hypersensitivity (Allergy) 02/2016
1	Colorectal Neoplasms (Colorectal Cancer) 03/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2012
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 10/2012
1	Autoimmune Diseases (Autoimmune Disease) 10/2012
1	Prostatic Neoplasms (Prostate Cancer) 10/2012
1	Chromosome Fragility 02/2012
1	Werner Syndrome (Werner's Syndrome) 09/2009
1	Premature Aging 09/2009

Drug/Important Bio-Agent (IBA)

21	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2006
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2004
7	Rad51 RecombinaseIBA 01/2022 - 11/2007
6	DNA HelicasesIBA 01/2020 - 05/2003
3	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2017
3	Phosphotransferases (Kinase)IBA 01/2022 - 01/2019
3	A-Form DNA (A-DNA)IBA 11/2015 - 10/2008
3	Cruciform DNA (Holliday Junctions)IBA 01/2014 - 10/2007
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022 - 01/2020
2	Biological ProductsIBA 01/2022 - 01/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2019
2	olaparibIBA 01/2022 - 01/2022
2	Mediator ComplexIBA 01/2022 - 07/2015
2	Pharmaceutical PreparationsIBA 12/2021 - 01/2021
2	CamptothecinIBA 01/2020 - 03/2010
2	RecQ HelicasesIBA 01/2019 - 09/2009
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2018 - 02/2016
2	ChromatinIBA 11/2015 - 03/2010
2	trioctyl phosphine oxide (TOPO)IBA 09/2010 - 05/2006
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Bloom syndrome proteinIBA 01/2022
1	talazoparibIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2022
1	CrizotinibIBA 12/2021
1	navitoclaxIBA 12/2021
1	Neutralizing AntibodiesIBA 12/2021
1	Fanconi Anemia Complementation Group D2 ProteinIBA 12/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2019
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	EndonucleasesIBA 02/2016
1	Replication Protein AIBA 07/2015
1	Thymine DNA GlycosylaseIBA 11/2014
1	MethyltransferasesIBA 03/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2013
1	telomerase RNA (bTR)IBA 05/2013
1	AutoantibodiesIBA 10/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2012
1	Antinuclear AntibodiesIBA 10/2012
1	Histones (Histone)IBA 03/2010
1	DNA-Activated Protein KinaseIBA 10/2008
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2008
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 10/2008
1	Methyl MethanesulfonateIBA 10/2008
1	Peptides (Polypeptides)IBA 10/2008
1	Saccharomyces cerevisiae ProteinsIBA 11/2007
1	NucleoproteinsIBA 11/2004

Therapy/Procedure

6	Therapeutics 01/2022 - 10/2012
2	Drug Therapy (Chemotherapy) 01/2019 - 03/2014
1	Immunotherapy 01/2022
1	Radiotherapy 12/2021
1	Aftercare (After-Treatment) 03/2014